Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rainer Weber

Showing results (201-210 of 252) with videos related to

Pageof 26
Sort By:
Circulation|February 4, 2009
Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study)Signe W Worm, Stephane De Wit, Rainer Weber, et al.
BMC Medicine|April 3, 2016
Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with HIV? A cohort collaborationCaroline A Sabin, Peter Reiss, Lene Ryom, et al.
The Journal of Infectious Diseases|May 10, 2002
A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infectionMilos Opravil, Bernard Hirschel, Adriano Lazzarin, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|June 15, 2010
Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs studyNina Friis-Møller, Rodolphe Thiébaut, Peter Reiss, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 22, 2020
Effect of Changes in Body Mass Index on the Risk of Cardiovascular Disease and Diabetes Mellitus in HIV-Positive Individuals: Results From the D:A:D StudyKathy Petoumenos, Locadiah Kuwanda, Lene Ryom, et al.
Gut|April 26, 2011
Systemic antibody responses to gut commensal bacteria during chronic HIV-1 infectionAnna Haas, Kathrin Zimmermann, Frederik Graw, et al.
AIDS (London, England)|August 7, 2019
Serious clinical events in HIV-positive persons with chronic kidney diseaseLene Ryom, Jens D Lundgren, Matthew Law, et al.
AIDS (London, England)|March 8, 2016
Improvements over time in short-term mortality following myocardial infarction in HIV-positive individualsCamilla Ingrid Hatleberg, Lene Ryom, Wafaa El-Sadr, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 18, 2018
Body Mass Index and the Risk of Serious Non-AIDS Events and All-Cause Mortality in Treated HIV-Positive Individuals: D: A: D Cohort AnalysisAmit C Achhra, Caroline Sabin, Lene Ryom, et al.
Anaerobe|February 1, 2020
Sonicate fluid inoculated into blood culture bottles does not improve diagnosis of periprosthetic joint infection caused by anaerobes. A retrospective analysisHeime Rieber, Andre Frontzek, Michael Alefeld, et al.
Pageof 26

Showing results (201-210 of 252) with videos related to

Sort By:
Pageof 26
Circulation|February 4, 2009
Diabetes mellitus, preexisting coronary heart disease, and the risk of subsequent coronary heart disease events in patients infected with human immunodeficiency virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D Study)Signe W Worm, Stephane De Wit, Rainer Weber, et al.
BMC Medicine|April 3, 2016
Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with HIV? A cohort collaborationCaroline A Sabin, Peter Reiss, Lene Ryom, et al.
The Journal of Infectious Diseases|May 10, 2002
A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infectionMilos Opravil, Bernard Hirschel, Adriano Lazzarin, et al.
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|June 15, 2010
Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs studyNina Friis-Møller, Rodolphe Thiébaut, Peter Reiss, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|December 22, 2020
Effect of Changes in Body Mass Index on the Risk of Cardiovascular Disease and Diabetes Mellitus in HIV-Positive Individuals: Results From the D:A:D StudyKathy Petoumenos, Locadiah Kuwanda, Lene Ryom, et al.
Gut|April 26, 2011
Systemic antibody responses to gut commensal bacteria during chronic HIV-1 infectionAnna Haas, Kathrin Zimmermann, Frederik Graw, et al.
AIDS (London, England)|August 7, 2019
Serious clinical events in HIV-positive persons with chronic kidney diseaseLene Ryom, Jens D Lundgren, Matthew Law, et al.
AIDS (London, England)|March 8, 2016
Improvements over time in short-term mortality following myocardial infarction in HIV-positive individualsCamilla Ingrid Hatleberg, Lene Ryom, Wafaa El-Sadr, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 18, 2018
Body Mass Index and the Risk of Serious Non-AIDS Events and All-Cause Mortality in Treated HIV-Positive Individuals: D: A: D Cohort AnalysisAmit C Achhra, Caroline Sabin, Lene Ryom, et al.
Anaerobe|February 1, 2020
Sonicate fluid inoculated into blood culture bottles does not improve diagnosis of periprosthetic joint infection caused by anaerobes. A retrospective analysisHeime Rieber, Andre Frontzek, Michael Alefeld, et al.
Pageof 26